BRISBANE, Calif., May 03, 2017 -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today announced it will host a company overview webinar on Wednesday, May 10, 2017, at 1:30 p.m. ET.
Dr. Cameron Durrant, chairman and CEO, will present an update on the company, its growth initiative progress and upcoming key milestones. The webinar will feature a presentation that can be accessed via the webcast link below. A question-and-answer session will follow.
Date: Wednesday, May 10, 2017
Time: 1:30 p.m. ET (10:30 a.m. PT)
Dial-in: 1-888-267-6301
Toll/International Dial-in: 1-719-457-2734
Webcast: http://public.viavid.com/index.php?id=124313
A telephone replay will be available approximately two hours after the call through June 10, 2017. Access the replay by dialing 1-844-512-2921 from the U.S. or 1-412-317-6671 from international locations, and entering the replay pin number: 8563194.
About KaloBios Pharmaceuticals, Inc.
KaloBios Pharmaceuticals, Inc. (OTC:KBIO) is an emerging biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases through innovative and responsible business models. Lead compounds in the KaloBios portfolio are benznidazole for the potential treatment of Chagas disease in the U.S., and the proprietary monoclonal antibodies, lenzilumab and ifabotuzumab, for the potential treatment of various solid and hematologic cancers such as CMML and potentially JMML. For more information, visit www.kalobios.com.
CONTACT: Investors: Mike Cole O: 949-259-4988 C: 949-444-1341 [email protected] Media: Lisa Guiterman O: 301-217-9353 C: 202-330-3431 [email protected]


Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns
Elon Musk Says Tesla Cybercab and Optimus Production Will Start Slowly Before Rapid Growth
Trump Signs Executive Order to Limit Wall Street Investment in Single-Family Homes
Nintendo Stock Jumps as Switch 2 Becomes Best-Selling Console in the U.S. in 2025
Rio Tinto Posts Strong Q4 Iron Ore and Copper Output on Operational Recovery
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit
Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model
Nvidia CEO Jensen Huang Plans China Visit Amid AI Chip Market Uncertainty
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance 



